AU2002339681A1 - Agonists and antagonists of glucomin for the treatment of metabolic disorders - Google Patents
Agonists and antagonists of glucomin for the treatment of metabolic disordersInfo
- Publication number
- AU2002339681A1 AU2002339681A1 AU2002339681A AU2002339681A AU2002339681A1 AU 2002339681 A1 AU2002339681 A1 AU 2002339681A1 AU 2002339681 A AU2002339681 A AU 2002339681A AU 2002339681 A AU2002339681 A AU 2002339681A AU 2002339681 A1 AU2002339681 A1 AU 2002339681A1
- Authority
- AU
- Australia
- Prior art keywords
- glucomin
- agonists
- antagonists
- treatment
- metabolic disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34043401P | 2001-12-12 | 2001-12-12 | |
US60/340,434 | 2001-12-12 | ||
PCT/IB2002/004621 WO2003049757A1 (en) | 2001-12-12 | 2002-10-14 | Agonists and antagonists of glucomin for the treatment of metabolic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002339681A1 true AU2002339681A1 (en) | 2003-06-23 |
Family
ID=23333329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002339681A Abandoned AU2002339681A1 (en) | 2001-12-12 | 2002-10-14 | Agonists and antagonists of glucomin for the treatment of metabolic disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002339681A1 (en) |
WO (1) | WO2003049757A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1102399A (en) * | 1997-10-21 | 1999-05-10 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
JP3538711B2 (en) * | 1997-10-29 | 2004-06-14 | 大塚製薬株式会社 | Smooth muscle proliferation inhibitory composition, arteriosclerosis diagnostic method and kit |
JP2003527067A (en) * | 1998-05-21 | 2003-09-16 | スミスクライン ビーチャム コーポレーション | ACRP30R1L, a homologue of ACRP30 (30 KD adipocyte complement-related protein) |
WO2000068380A2 (en) * | 1999-05-11 | 2000-11-16 | Incyte Genomics, Inc. | Extracellular matrix and adhesion-associated proteins |
CA2374387A1 (en) * | 1999-05-27 | 2000-12-07 | Zymogenetics, Inc. | Adipocyte complement related protein homolog zacrp7 |
MXPA02006834A (en) * | 2000-01-14 | 2005-07-01 | Genset Sa | Obg3 globular head and uses thereof for decreasing body mass. |
-
2002
- 2002-10-14 AU AU2002339681A patent/AU2002339681A1/en not_active Abandoned
- 2002-10-14 WO PCT/IB2002/004621 patent/WO2003049757A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003049757A1 (en) | 2003-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002339691A1 (en) | Agonists and antagonists of prolixin for the treatment of metabolic disorders | |
AU2003223579A1 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
IL209842A0 (en) | Compounds for the treatment of metabolic disorders | |
AU2003213787A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
AU2002363935A1 (en) | Composition and method for the treatment of anorectal disorders | |
AU2002339673A1 (en) | Agonists and antagonists of ryzn for the treatment of metabolic disorders | |
AU2002258798A1 (en) | Methods for the treatment of hepatic disorders | |
AU2002328173A1 (en) | Omoxin agonists and antagonists for use in the treatment of metabolic disorders | |
AU2002363228A1 (en) | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 | |
AU2002339680A1 (en) | Agonists and antagonists of bromix for the treatment of metabolic disorders | |
AU2002339682A1 (en) | Emergen agonists and antagonists for use in the treatment of metabolic disorders | |
AU2002321769A1 (en) | Agonists and antagonists of cobesin for the treatment of metabolic disorders | |
AU2002329001A1 (en) | Agonists and antagonists of cylixin for the treatment of metabolic disorders | |
AU2002324300A1 (en) | Agonists and antagonists of moceptin for the treatment of metabolic disorders | |
AU2002321770A1 (en) | Agonists and antagonists of genceptin for the treatment of metabolic disorders | |
AU2002339685A1 (en) | Agonists and antagonists of oxifan for the treatment of metabolic disorders | |
AU2002324297A1 (en) | Agonists and antagonists of moxifin for the treatment of metabolic disorders | |
AU2002313580A1 (en) | Xobesin agonists and antagonists for the treatment of metabolic disorders | |
AU2002321761A1 (en) | Agonists and antagonists of disomet for the treatment of metabolic disorders | |
AU2002321766A1 (en) | Agonists and antagonists of obesingen for the treatment of metabolic disorders | |
AU2002339681A1 (en) | Agonists and antagonists of glucomin for the treatment of metabolic disorders | |
AU2002339683A1 (en) | Agonist and antagonists of redax for the treatment of metabolic disorders | |
AU2002321767A1 (en) | Tr xidatin agonists and antagonists treatment of metabolic disorders | |
AU2002339668A1 (en) | Treatment of metabolic disorders with xitar agonists and antagonists | |
AU2002324299A1 (en) | Genoxit agonists and antagonists for use in the treatment of metabolic disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |